5 Best Dividend Stocks to Buy Now According to Billionaire Kerr Neilson

Page 5 of 5

1. Gilead Sciences, Inc. (NASDAQ: GILD)

Neilson’s Stake Value: $107,890,000
Percentage of Kerr Neilson’s 13F Portfolio: 2.4%
Dividend Yield: 4.21%
No. of Hedge Fund Holders: 65

Coming in 1st on our list is Gilead Sciences, Inc. (NASDAQ: GILD). This biopharmaceutical company is headquartered in Foster City, California. It focuses on research and the development of antiviral drugs. Gilead Sciences, Inc. (NASDAQ: GILD) has been working on these drugs to treat HIV, hepatitis B, hepatitis C, and influenza.

The company’s Trodelvy new subgroup data has shown benefits for relapsed or refractory metastatic triple-negative breast cancer (TNBC) treatment. Gilead Sciences, Inc.’s (NASDAQ: GILD) announcement of the new data from the company’s Phase 3 ASCENT study made the declaration.

Nelson Roberts Investment Advisors’ in their Q3 2020 investor letter talked about GILD. Here is what the fund said:

“In the healthcare sector, we sold our position in Gilead (NASDAQ: GILD) as there are no near or medium-term growth drivers for the company. Its popular HIV drug, Truvada, is going off patent this year. Additionally, UnitedHealth Group said it would not cover Gilead’s other HIV drug, Descovy. Lastly, the multiple acquisitions that Gilead has made recently are not ready for prime time, and it will likely be two years or more before any of Gilead’s new drugs have a meaningful impact on revenue.”

You can also take a peek at 10 Best American Dividend Stocks to Invest In and 15 Best American Stocks to Buy Now.

Page 5 of 5